Yasin Keshvargar

Davis Polk advised the sales agent in connection with an SEC-registered at-the-market offering by InflaRx N.V. of its shares of common stock for up to an aggregate amount of $50…

Davis Polk advised the representatives of the underwriters in connection with an initial public offering of Inventiva S.A.’s 7,478,261 American Depositary Shares. Aggregate gross…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Energizer Holdings, Inc. of $600 million aggregate principal amount…

As part of the transaction, T-Mobile used proceeds from a new $16 billion stock offering to purchase its shares from SoftBank

Davis Polk advised the dealer manager in connection with an SEC-registered rights offering by Liberty Media Corporation. A total of 29,594,089 new shares were subscribed for in the rights…

Davis Polk advised the representatives of the underwriters in connection with the $230 million initial public offering of 12,105,263 shares of common stock of Generation Bio Co., which…

Davis Polk advised the underwriters in connection with the $487 million SEC-registered initial public offering by Legend Biotech Corporation of 21,188,750 American Depositary Shares, each…

Davis Polk advised the placement agent in connection with a private placement pursuant to Rule 4(a)(2) by Humanigen Inc. of $72 million of common stock. Humanigen Inc. is a clinical…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering of an additional $300 million aggregate principal amount of 6.250%…

Davis Polk advised ADC Therapeutics SA on its SEC-registered initial public offering of 14,082,475 common shares, which included the exercise in full by the underwriters of their option to…